This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: The University of North Carolina at Chapel Hill, Regents of the University of Minnesota. Active years: 2022-2025.
Company Filing History:
2 out of 1,325 
1 out of 2,367 
Years Active: 2022-2025
Title: Innovations by James M Coghill
Introduction
James M Coghill is a notable inventor based in Wake Forest, NC (US). He has made significant contributions to the field of medical science, particularly in the area of transplantation and graft-versus-host disease. With a total of 2 patents, his work has the potential to improve patient outcomes in critical health situations.
Latest Patents
James M Coghill's latest patents include innovative methods for attenuating graft-versus-host disease and opportunistic infections. The first patent relates to methods for reducing graft-versus-host disease after the transplantation of a graft comprising hematopoietic stem cells. This invention also addresses methods for limiting opportunistic microbial infections in subjects post-transplantation. His second patent focuses on compositions and methods for preventing and treating graft-versus-host disease, highlighting the role of ILC2 cells in the pathogenesis of this condition. The infusion of IL-33 activated ILC2 cells into patients has shown promise in ameliorating the disease and improving survival rates.
Career Highlights
Throughout his career, James M Coghill has worked with prestigious institutions, including the University of North Carolina at Chapel Hill and the Regents of the University of Minnesota. His research has been pivotal in advancing the understanding of graft-versus-host disease and its treatment.
Collaborations
James has collaborated with esteemed colleagues such as Bruce Robert Blazar and Benjamin Vincent. Their combined expertise has contributed to the development of innovative solutions in the field of transplantation.
Conclusion
James M Coghill's contributions to medical science through his patents and collaborations have the potential to significantly impact patient care in transplantation. His work exemplifies the importance of innovation in addressing complex health challenges.